Normal view MARC view ISBD view

Does the new generation of drug-eluting stents render bare metal stents obsolete?. [Review]

MedStar author(s):

Citation: Cardiovascular Revascularization Medicine. 18(6):456-461, 2017 SepPMID: 28941481Institution: MedStar Heart & Vascular InstituteForm of publication: Journal ArticleMedline article type(s): Journal Article | ReviewSubject headings: *Cardiovascular Agents/tu [Therapeutic Use] | *Coronary Artery Disease/th [Therapy] | *Drug-Eluting Stents | *Stents | Angioplasty, Balloon, Coronary/mt [Methods] | Drug-Eluting Stents/ae [Adverse Effects] | Humans | Metals/ae [Adverse Effects] | Percutaneous Coronary Intervention/mt [Methods]Year: 2017 Local holdings: Available in print through MWHC library: 2002 - presentISSN:

1878-0938

Name of journal: Cardiovascular revascularization medicine : including molecular interventionsAbstract: The development of bare metal coronary stents revolutionized the treatment of coronary artery disease by reducing rates of acute vessel closure and restenosis associated with balloon angioplasty. However, bare metal stents (BMS) resulted in high rates of restenosis and led to the development of drug-eluting stents (DES). Those first-generation DES were followed by successive generations of DES that included improvements, such as biodegradable and more biocompatible polymers. Despite the superiority of the current DES compared to BMS, a subset of patients still receives BMS. The following paper reviews the literature comparing the safety and efficacy of newer generation DES to BMS in such patients and ultimately challenges the use of BMS in contemporary current DES era. Copyright (c) 2017 Elsevier Inc. All rights reserved.All authors: Buchanan K, Steinvil A, Waksman RFiscal year: FY2018Digital Object Identifier:

https://dx.doi.org/10.1016/j.carrev.2017.03.027

Date added to catalog: 2017-09-29

Holdings ( 1 )
Title notes ( 3 )

Holdings
Item type	Current library	Collection	Call number	Status	Date due	Barcode
Journal Article	MedStar Authors Catalog	Article	28941481	Available		28941481

Available in print through MWHC library: 2002 - present

The development of bare metal coronary stents revolutionized the treatment of coronary artery disease by reducing rates of acute vessel closure and restenosis associated with balloon angioplasty. However, bare metal stents (BMS) resulted in high rates of restenosis and led to the development of drug-eluting stents (DES). Those first-generation DES were followed by successive generations of DES that included improvements, such as biodegradable and more biocompatible polymers. Despite the superiority of the current DES compared to BMS, a subset of patients still receives BMS. The following paper reviews the literature comparing the safety and efficacy of newer generation DES to BMS in such patients and ultimately challenges the use of BMS in contemporary current DES era. Copyright (c) 2017 Elsevier Inc. All rights reserved.

English